Showing results (891-900 of 23,418) with videos related to
Sort By:
Pageof 2,342
The Journal of Infectious Diseases|September 9, 2000
Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitisW Liu, C Shum, D F Martin, et al.The Journal of Infectious Diseases|September 9, 2000
Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivoJ Ferbas, J V Giorgi, S Amini, et al.The Journal of Infectious Diseases|September 9, 2000
Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxinM J Schultz, D P Olszyna, E de Jonge, et al.The Journal of Infectious Diseases|February 22, 2001
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn, J N Martin, M E Roland, et al.The Journal of Infectious Diseases|February 22, 2001
The changing epidemiology of salmonella: trends in serotypes isolated from humans in the United States, 1987-1997S J Olsen, R Bishop, F W Brenner, et al.The Journal of Infectious Diseases|February 22, 2001
Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotypingS Franks, K A Koram, G E Wagner, et al.The Journal of Infectious Diseases|February 22, 2001
T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19R Franssila, K Hokynar, K HedmanThe Journal of Infectious Diseases|February 22, 2001
Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvantM Saito, S Otake, M Ohmura, et al.The Journal of Infectious Diseases|February 22, 2001
Protection against bacteremic pneumococcal infection by antibody to pneumolysinD M Musher, H M Phan, R E BaughnThe Journal of Infectious Diseases|March 10, 2001
CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimusA F Hassan-Walker, A L Vargas Cuero, F M Mattes, et al.Pageof 2,342